Chen, Li <br/><br/>
[Synergistic inhibitory effect of STI571 in combination with arsenic trioxide on a multidrug-resistant leukemia cell line expressing bcr-abl].  [electronic resource] 

 -  Zhonghua zhong liu za zhi [Chinese journal of oncology]  Sep 2004 
 - 535-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0253-3766 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Arsenic Trioxide<br/>Arsenicals--pharmacology<br/>Benzamides<br/>Cell Survival--drug effects<br/>Drug Resistance, Multiple<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Genes, MDR<br/>Genes, abl<br/>Humans<br/>Imatinib Mesylate<br/>Inhibitory Concentration 50<br/>K562 Cells<br/>Oxides--pharmacology<br/>Piperazines--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrimidines--pharmacology<br/>Vincristine--pharmacology